Back
Anonymous 1
Hey I am on Medialย โขย 9m
10x far better than USA. You know what's the issue with generic medicine. Quality Concerns & Regulatory Issues Many small manufacturers do not meet strict Good Manufacturing Practices (GMP), leading to variations in drug efficacy and safety. The Central Drugs Standard Control Organization (CDSCO) struggles with strict enforcement, leading to substandard or counterfeit drugs entering the market. The US FDA and EU have flagged multiple Indian pharma plants for violations, affecting trust in Indian generics globally.
Replies (1)
More like this
Recommendations from Medial
Chirotpal Das
Building an AI eco-s...ย โขย 10m
๐กย Did you know India๐ฎ๐ณ is leading a ๐ ๐๐ง๐จ๐ฆ๐ข๐ ๐ซ๐๐ฏ๐จ๐ฅ๐ฎ๐ญ๐ข๐จ๐ง? Theย ๐๐๐ง๐จ๐ฆ๐๐๐ง๐๐ข๐ ๐๐ซ๐จ๐ฃ๐๐๐ญย is leading the way for a genomic revolution. What this means? โ ย ๐๐๐ซ๐ฌ๐จ๐ง๐๐ฅ๐ข๐ณ๐๐ ๐๐๐๐ฅ๐ญ๐ก๐๐๐ซ๐: By developing aย ๐ซ
See More
Mridul Das
Introvert!ย โขย 9m
This is mind blowing ๐คฏ. The farmaceutical business is really the whale ๐. โก๏ธ This Bangalore based Pharmacy-focused supply chain and marketplace platform Saveo has achieved remarkable growth, scaling 103X ๐ฅsince its inception. โก๏ธIn 2020 their reve
See More
My Dawai Wala
India's Health First...ย โขย 5m
Day #7 Real Medicine. Not Maybes. Letโs talk about a silent threat in Indian healthcare: โข Fake pills โข Near-expiry stock โข Unexplained substitutions This isnโt rare. Itโs real and itโs happening every day. โข Counterfeit drugs make up 8โ10% of Ind
See More
Aakash kashyap
Building JalSeva and...ย โขย 1y
โโImportant For All โโ A $450 million Indian startup, Zest Money, shut down due to strict RBI regulations, highlighting the risks of external factors in business. ๐ $450 million valuation: Zest Money was a leading player in the buy now pay later s
See More
Download the medial app to read full posts, comements and news.